SavedAdd your journal

Journals / Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi / 2016 / Cilt: 62 - Sayı: 1

Behçet hastalarında fibromiyalji sendromunun yaşam kalitesi üzerine etkisi

Impact of fibromyalgia syndrome on quality of life in patients with Behçet’s disease

Nursad ÇİFÇİ
Tuba GÜLER
Yeşim GARİP
Fulya DÖRTBAŞ
Ayşe Aslıhan KARCI
Pages
45–50
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Behçet’s disease patients with FMS scored significantly higher in headache, central nervous system involvement, patient’s and physician’s impression of disease activity subgroups of BDCAF, and significantly lower in all subgroups of SF-36 (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: In this study, we aimed to investigate the prevalence of fibromyalgia syndrome (FMS) among patients with Behçet’s disease (BD) and to assess the impact of FMS on quality of life in this patient population.Patients and methods: Between September 2014 and December 2014 60 BD patients and 60 age- and sex-matched healthy controls were included in the study.
📊
Key Findings & Data:A Short Form 36 (SF-36) was used to assess the quality of life.
💡
Conclusion & Impact:Behçet’s disease patients with FMS scored significantly higher in headache, central nervous system involvement, patient’s and physician’s impression of disease activity subgroups of BDCAF, and significantly lower in all subgroups of SF-36 (p
🔬Design:Survey & Empirical Study
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: In this study, we aimed to investigate the prevalence of fibromyalgia syndrome (FMS) among patients with Behçet’s disease (BD) and to assess the impact of FMS on quality of life in this patient population.Patients and methods: Between September 2014 and December 2014 60 BD patients and 60 age- and sex-matched healthy controls were included in the study. The presence of FMS was evaluated based on the American College of Rheumatology (ACR) diagnostic criteria. The tender point count (TPC) scores were recorded. The disease severity of FMS was measured with the Fibromyalgia Impact Questionnaire (FIQ), while the disease activity of BD was determined by the Behçet Disease Current Activity Form (BDCAF). A Short Form 36 (SF-36) was used to assess the quality of life. Results: According to the ACR criteria, the prevalence of FMS was 16.7% in BD patients and 3.3% in the controls, indicating significantly higher rates in the FMS group with BD [odds ratio (OR)= 5.8; confidence interval (CI) 95% (1.21-27.72)] (p=0.015), compared to the controls. Behçet’s disease patients with FMS scored significantly higher in headache, central nervous system involvement, patient’s and physician’s impression of disease activity subgroups of BDCAF, and significantly lower in all subgroups of SF-36 (p

Özet

Amaç: Bu çalışmada Behçet hastalarında fibromiyalji sendromunun (FMS) sıklığı araştırıldı ve FMS'nin bu hasta popülasyonunda yaşam kalitesi üzerindeki etkisi değerlendirildi.Hastalar ve yöntemler: Eylül 2014 - Aralık 2014 tarihleri arasında 60 Behçet hastası ve 60 yaş ve cinsiyet eşleştirilmiş sağlıklı kontrol çalışmaya alındı. Fibromiyalji sendromu varlığı Amerikan Romatoloji Derneği (ACR) tanı kriterlerine göre değerlendirildi. Hassas nokta sayısı (TPC) skorları kaydedildi. Fibromiyalji sendromu hastalık şiddeti Fibromiyalji Etki Anketi (FIQ) ile ölçülürken, Behçet hastalık aktivitesi Behçet Hastalığı Anlık Aktivite Formu (BDCAF) ile belirlendi. Yaşam kalitesi, Kısa Form-36 (KF-36) ile değerlendirildi.Bulgular: ACR kriterlerine göre, FMS sıklığı Behçet hastalarında %16.7 ve kontrollerde %3.3 idi; bu da, kontrollere kıyasla Behçet hastalıklı FMS grubunda anlamlı düzeyde daha yüksek oranları gösteriyordu [olasılık oranı (OR)= 5.8 güven aralığı (GA) %95 (1.21-27.72)] (p=0.015). Fibromiyalji sendromu olmayanlara kıyasla, FMS'li Behçet hastalarında BDCAF'nin baş ağrısı, merkezi sinir sistemi tutulumu, hasta ve hekim hastalık aktivitesi algısı alt gruplarında anlamlı düzeyde daha yüksek ve KF-36'nın tüm alt gruplarında anlamlı düzeyde daha düşük skorlama görüldü (p

🔖

Cite This Article

ÇİFÇİ, N., GÜLER, T., GARİP, Y., DÖRTBAŞ, F., KARCI, A. A. (2022). Behçet hastalarında fibromiyalji sendromunun yaşam kalitesi üzerine etkisi. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, Cilt: 62 - Sayı: 1, 45–50. https://ajindex.com/articles/628651

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Yazici A, Cefle A, Savli H. The frequency of MEFV gene mutations in Behcet᾿s disease and their relation with clinical findings. Rheumatol Int 2012;32:3025-30
  2. Bodur H, Borman P, Ozdemir Y, Atan C, Kural G. Quality of life and life satisfaction in patients with Behçet᾿s disease: relationship with disease activity. Clin Rheumatol 2006;25:329-33
  3. Bicer A. Musculoskeletal Findings in Behcet᾿s Disease. Patholog Res Int 2012;2012:653806
  4. Plazier M, Ost J, Stassijns G, De Ridder D, Vanneste S. Pain characteristics in fibromyalgia: understanding the multiple dimensions of pain. Clin Rheumatol 2015;34:775-83
  5. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28
  6. Haliloglu S, Carlioglu A, Akdeniz D, Karaaslan Y, Kosar A. Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity. Rheumatol Int 2014;34:1275-80
  7. Kapoor SR, Hider SL, Brownfield A, Mattey DL, Packham JC. Fibromyalgia in patients with rheumatoid arthritis: driven by depression or joint damage? Clin Exp Rheumatol 2011;29:88-91
  8. Demirdal S, Cakir T, Tugrul T, Subasi V. Coexisting of fibromyalgia syndrome and ankylosing spondylitis. Acta Medica Mediterranea 2013;29:827
  9. Torrente-Segarra V, Carbonell-Abelló J, Castro-Oreiro S, Manresa Domínguez JM. Association between fibromyalgia and psychiatric disorders in systemic lupus erythematosus. Clin Exp Rheumatol 2010;28:22-6
  10. Salaffi F, De Angelis R, Carotti M, Gutierrez M, SarziPuttini P, Atzeni F. Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity. Rheumatol Int 2014;34:1103-10
  11. Criteria for diagnosis of Behçet᾿s disease. International Study Group for Behçet᾿s Disease. Lancet 1990;335:1078-80
  12. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72
  13. Sarmer S, Ergin S, Yavuzer G. The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 2000;20:9-12
  14. Hamuryudan V, Fresko I, Direskeneli H, Tenant MJ, Yurdakul S, Akoglu T, et al. Evaluation of the Turkish translation of a disease activity form for Behçet᾿s syndrome. Rheumatology (Oxford) 1999;38:734-6
  15. Price